C3L2U0 AF NFT

6,7-dimethyl-8-ribityllumazine synthase

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeigrzcnhgbto7le2llatndhwwgmvigpkkn7gbacco7db7ql35r3vne/metadata.json
IPFS of structure file: 
bafybeid3ieaiaqcufhdtvkqr6o6schuz43ri7z4osztylpvq4bq4yc6lcy/AF-C3L2U0-F1-model_v2.pdb
First NFT owner address (eip-55): 
0xa6D533dDeEB1DAde828e7Cc2ca20af4B56132a5C
First NFT owner address (bech32): 
genesis15m2n8h0wk8ddaq5w0npv5g90fdtpx2ju27dp3f
Current NFT ID #346433 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1_w

NFT id:
346433
Accession (UniProt):
C3L2U0
Name::
6,7-dimethyl-8-ribityllumazine synthase
Experimental Method:
Predicted structure
Sequence source:
Clostridium botulinum (strain 657 / Type Ba4)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT C3L2U0 research and analysis (ICN3D with VR)

FASTA sequences

>sp|C3L2U0|RISB_CLOB6 6,7-dimethyl-8-ribityllumazine synthase OS=Clostridium botulinum (strain 657 / Type Ba4) OX=515621 GN=ribH PE=3 SV=1 MKIYEGKLTAEGLKVGIIVSRFNEFITSKLLAGSIDCLKRHGAKEDNIEVCWVPGAFEIPVIAKKMASKGKYDAVICLGAVIRGATPHFDYVSSEVSKGVAHVSLDKEVPVIFGVLTTNTIEQAIERAGTKAGNKGYDAAMSAIEMSNLMKILD